View all news

Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

10/15/2021

Multimedia Files:

View all news
Questions? Please contact us:
1-800-950-5089 investor-relations@its.jnj.com